Advertisement
Screener

Iguana Healthcare Management, LLC Current Holdings: USA Stocks

Iguana Healthcare Management, LLC current holdings: USA Stocks

Iguana Healthcare Management, LLC reported $0.10 billion in share positions in stocks (listed in the US), 26 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are RARE, ZBH, AMGN.

  • RARE: Country of operation United States; Class COM; Shares 200,000; Value $14,188,000.
  • ZBH: Country of operation United States; Class COM; Shares 85,000; Value $11,052,000.
  • AMGN: Country of operation United States; Class COM; Shares 55,000; Value $9,175,000.
  • PFE: Country of operation United States; Class COM; Shares 250,000; Value $8,468,000.

Form 13F-HR as filed (SEC CIK 1597549): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.

Performance is each holding's price change from its close on the 2016-09-30 quarter end to its latest retained close (2026-09-29, or the date shown for a stock that stopped trading). Price only; dividends are not included. A stock that split in the period is restated by the split ratio in its own Form 8-K; a dash marks a holding with no retained closes.

StockCountry of operationClassSharesValue% of listedQuarter endFiledPerformance
RARE
ULTRAGENYX PHARMACEUTICAL IN
United StatesCOM200,000$14,188,00013.47%2016-09-302016-11-14— split 2025-12-29, ratio not on file
ZBH
ZIMMER BIOMET HLDGS INC
United StatesCOM85,000$11,052,00010.49%2016-09-302016-11-14-27.64%
AMGN
AMGEN INC
United StatesCOM55,000$9,175,0008.71%2016-09-302016-11-14+153.97%
PFE
PFIZER INC
United StatesCOM250,000$8,468,0008.04%2016-09-302016-11-14-10.63%
BIIB
BIOGEN INC
United StatesCOM20,000$6,261,0005.94%2016-09-302016-11-14-27.46%
ALNY
ALNYLAM PHARMACEUTICALS INC
United StatesCOM75,000$5,083,0004.83%2016-09-302016-11-14— split 2016-10-06, ratio not on file
GILD
GILEAD SCIENCES INC
United StatesCOM60,000$4,747,0004.51%2016-09-302016-11-14+91.20%
MRK
MERCK & CO INC
United StatesCOM75,000$4,681,0004.44%2016-09-302016-11-14+150.68%
GKOS
GLAUKOS CORP
United StatesCOM120,000$4,529,0004.30%2016-09-302016-11-14+320.11%
EXEL
EXELIXIS INC
United StatesCOM350,000$4,477,0004.25%2016-09-302016-11-14+358.56%
SUPN
SUPERNUS PHARMACEUTICALS INC
United StatesCOM150,000$3,710,0003.52%2016-09-302016-11-14+77.80%
BMY
BRISTOL MYERS SQUIBB CO
United StatesCOM65,000$3,505,0003.33%2016-09-302016-11-14+16.58%
MRUS
MERUS N V
COM200,000$3,350,0003.18%2016-09-302016-11-14
ELV
ANTHEM INC
United StatesCOM25,000$3,133,0002.97%2016-09-302016-11-14+213.41%
MDRX
ALLSCRIPTS HEALTHCARE SOLUTN
United StatesCOM225,000$2,963,0002.81%2016-09-302016-11-14
PCRX
PACIRA PHARMACEUTICALS INC
United StatesCOM75,000$2,567,0002.44%2016-09-302016-11-14— split 2024-08-09, ratio not on file
IONS
IONIS PHARMACEUTICALS INC
United StatesCOM50,000$1,832,0001.74%2016-09-302016-11-14+25.25%
ACHC
ACADIA HEALTHCARE COMPANY IN
United StatesCOM35,000$1,734,0001.65%2016-09-302016-11-14-43.41%
SRPT
SAREPTA THERAPEUTICS INC
United StatesCOM25,000$1,535,0001.46%2016-09-302016-11-14— split 2021-01-08, ratio not on file
PACB
PACIFIC BIOSCIENCES CALIF IN
United StatesCOM150,000$1,344,0001.28%2016-09-302016-11-14— split 2016-12-15, ratio not on file
MGNX
MACROGENICS INC
United StatesCOM40,000$1,196,0001.14%2016-09-302016-11-14— split 2019-02-06, ratio not on file
BSX
BOSTON SCIENTIFIC CORP
United StatesCOM50,000$1,190,0001.13%2016-09-302016-11-14+84.37%
THC
TENET HEALTHCARE CORP
United StatesCOM NEW50,000$1,133,0001.08%2016-09-302016-11-14+1036.80%
ADMA
ADMA BIOLOGICS INC
United StatesCOM150,000$1,086,0001.03%2016-09-302016-11-14— split 2018-12-20, ratio not on file
ACAD
ACADIA PHARMACEUTICALS INC
United StatesCOM25,000$795,0000.75%2016-09-302016-11-14— split 2021-03-09, ratio not on file
ESPR
ESPERION THERAPEUTICS INC NE
United StatesCOM40,000$554,0000.53%2016-09-302016-11-14

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet